Refractory Epilepsy Recruiting Phase 2 / 3 Trials for Propofol (DB00818)

IndicationStatusPhase
DBCOND0032649 (Refractory Epilepsy)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03115489Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status EpilepticusPrevention